ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Decision Diagnostics Corporation (CE)

Decision Diagnostics Corporation (CE) (DECN)

0,0001
0,0001
( 9 900,00% )
Mis à jour : 15:30:09

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,0001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
2 237 804
0,000001 Fourchette du Jour 0,0001
0,000001 Plage de 52 semaines 0,0001
Clôture Veille
0,000001
Ouverture
0,000001
Dernière Transaction
836228
@
0.0001
Dernière heure de transaction
15:35:52
Volume moyen (3 m)
99 234
Volume financier
US$ 224
VWAP
0,0001

DECN Dernières nouvelles

The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)

  July 6, 2020 -- Investorshub NewsWire -- via Microcap Daily -- BY JACOB WATSON -- Alternet Systems, Inc. (OTCMKTS: ALYI) continues to see higher highs and higher lows...

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology GenViroTM Anticipated to be Commercial Ready in Summer 2020...

DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...

DECN SETS PLAN TO MAKE UPCOMING PATENT INFRINGEMENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOVERY ++ COMPANY PLANS TO BUILD A FOUNDATION FOR...

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN NEXT 7 DAYS, CLINICAL TRIALS TESTING TO BEGIN IN MAY ++ EQUITY FUND IN STEALTHY MOVE TRIED TO GAIN...

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE GOVERNMENT SHUTDOWN ++ COMPANY ALSO REACHES PRICING...

DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS

  ++ COMPANY HAS ALSO AGREED TO MANUFACTURE A HOUSE BRAND PRODUCT FOR A “BIG BOX” AND WILL PROVIDE A FORECAST AND PRICE TERMS ONCE WE AGREE IN COMING DAYS ++ LOS...

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)   ++ COMPANIES ANTICIPATE ANOTHER PRECEDENTIAL RULING FROM THE...

DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY

++ COMPANY ALSO READIES IMMINENT APPEAL IN THE JOHNSON & JOHNSON PATENT INFRINGEMENT MATTER WITH THE U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT ++ Los Angeles, CA -- December 17, 2018...

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATIONS ++ IP AND PRODUCTS STRATEGY IS PUT IN PLACE TO INCREASE...

DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018

++ DECN TO LAUNCH GENCHOICE! PRODUCT IN SELECT INTERNATIONAL MARKETS JANUARY 2, 2019 AND TO FILE FOR CE MARK IN THE EU AND HEALTH CANADA APPROVAL IN EARLY 2019 ++ Los Angeles, CA -- December 4...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
19.9E-599001.0E-60.00011.0E-6117641.0E-6CS
49.9E-599001.0E-60.00011.0E-61408151.0E-6CS
129.9E-599001.0E-60.00011.0E-6992341.0E-6CS
269.9E-599001.0E-60.00011.0E-6911961.0E-6CS
529.9E-599001.0E-60.00011.0E-6944141.0E-6CS
156-0.0025-96.15384615380.00260.00271.0E-61160740.00049994CS
260-0.0186-99.46524064170.01870.4971.0E-619995250.16282879CS

DECN - Frequently Asked Questions (FAQ)

What is the current Decision Diagnostics (CE) share price?
The current share price of Decision Diagnostics (CE) is US$ 0,0001
What is the 1 year trading range for Decision Diagnostics (CE) share price?
Decision Diagnostics (CE) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
DOMWFPrime Drink Group Corporation (PK)
US$ 0,14
(19 900,00%)
10,04k
LCDXCaliber Imaging and Diagnostics Inc (CE)
US$ 0,02
(19 900,00%)
30,86k
FPPPFieldpoint Petroleum Corp (CE)
US$ 0,000134
(13 300,00%)
150
FHBCFernhill Beverage Inc (CE)
US$ 0,000131
(13 000,00%)
153
EARIEntertainment Arts Research Inc (PK)
US$ 0,0001
(9 900,00%)
3,47M
HTRCHunter Creek Mining Co (CE)
US$ 0,000005
(-99,99%)
2k
NKWFFOceanic Wind Energy Inc (CE)
US$ 0,00002
(-99,93%)
1 000
HXPNHarris Exploration Inc (CE)
US$ 0,000001
(-99,92%)
8k
SEANSAEAN Group Inc (PK)
US$ 0,01
(-99,67%)
100
RDVWFRadView Software Ltd (CE)
US$ 0,000001
(-99,25%)
100
PHILPHI Group Inc (PK)
US$ 0,0004
(100,00%)
857,41M
RDARRaadr Inc (PK)
US$ 0,0012
(4,35%)
195,15M
RONNRonn Motor Group Inc (PK)
US$ 0,0003
(-25,00%)
179,23M
HCMCHealthier Choices Management Corporation (PK)
US$ 0,000001
(0,00%)
159,66M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,00015
(-25,00%)
139,5M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock